Detalhe da pesquisa
1.
The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants.
Acta Pharmacol Sin
; 43(4): 1024-1032, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321613